Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. CT ORDER Other Confidential Order
  2. DEFA14A Proxy Proxy Materials
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. CT ORDER Other Confidential Order
  5. DEFA14A Proxy Proxy Materials
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. EFFECT Other Notice of Effectiveness
  8. S-3MEF Other S-3MEF
  9. DEFA14A Proxy Proxy Materials
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. DEFA14A Proxy Proxy Materials
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. DEFA14A Proxy Proxy Materials
  14. EFFECT Other Notice of Effectiveness
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. CT ORDER Other Confidential Order
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 8-A12B/A Other Registration Statement
  19. DEFA14A Proxy Proxy Materials
  20. DEFA14A Proxy Proxy Materials

Page 4 of 5 · 93 filings